http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-055407-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
filingDate 2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-055407-A2
titleOfInvention GEL TYPE AQUATIC PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATION, PROCEDURE FOR THE PREPARATION AND USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT
abstract A gel-like aqueous pharmaceutical composition for subcutaneous administration, comprising bisphosphonic acids or their pharmaceutically acceptable salts. The composition has at least one compound that inhibits the diffusion of the active substance in the tissue, the active substance being present in dissolved form in the composition, and the composition having a viscosity> -220 mPa * s. A process for the production of this composition and the use of said compositions for the preparation of a medicament are also disclosed. Through this composition it is possible to locally administer relatively high concentrations of bisphosphonates without incompatibilities, to treat bone metabolism disorders. Claim 1: Gel-like aqueous pharmaceutical composition for subcutaneous administration, comprising bisphosphonic acids selected from: clodronate, etidronate, risedronate, zoledronate, tiludronate, pamidronate, cimadronate (YM175) and alendronate, or its physiologically acceptable salts, characterized in that it contains at least one compound that inhibits the diffusion of the active substance in the tissues, which is a natural polymer and is selected from the group consisting of cellulose derivatives, alginic acid derivatives, dextrans, gelatins, collagen, hyaluronic acids and / or dermatan and heparan sulfates, the active substance being present in dissolved form in the composition and the composition having a viscosity> - 220 mPa * s.
priorityDate 2000-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535486
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3699
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532918
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408184029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494003

Total number of triples: 46.